Press release
Autoimmune Hepatitis Market, By Type (Type 1, Type 2), Treatment (Medications, Liver Transplant, Others)
Autoimmune hepatitis is a rare but deadly liver condition. The body assaults itself when it misidentifies healthy tissue and cells as infected tissue and cells, and antibodies are produced to attack the healthy liver cells. Autoimmune hepatitis can strike suddenly or progress gradually. The aetiology of the condition is unknown, but it may be linked to other systemic diseases or pharmaceutical exposure in some cases.View Full Report: https://www.databridgemarketresearch.com/reports/global-autoimmune-hepatitis-market
In recent years, the autoimmune hepatitis market is anticipated to grow rapidly during the forecast period. According to the 2019 study "Burden of Liver Diseases in the World," liver illness causes roughly 2 million fatalities worldwide, with 1 million deaths due to cirrhosis complications and 1 million deaths due to viral hepatitis and hepatocellular cancer. Cirrhosis is the 11th most prevalent cause of mortality globally, while liver cancer is the 16th most common cause of death. They are responsible for 3.5 percent of all deaths worldwide.
Data Bridge Market Research analyses that the autoimmune hepatitis market was valued at USD 156.76 million in 2021 and is expected to reach USD 210.61 million by 2029, registering a CAGR of 3.70% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Opportunities
Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the autoimmune hepatitis market growth. Along with this, surging drug approvals and launches will increase the market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the autoimmune hepatitis market growth during the forecast period.
Drivers
Rise in the prevalence of autoimmune hepatitis
The rising prevalence of autoimmune hepatitis is a major factor driving the autoimmune hepatitis market's growth rate. Enlarged veins in the oesophagus, fluid accumulation in the abdomen, liver failure, and liver cancer are some of the problems linked with such diseases.
Some of the major players operating in the autoimmune hepatitis market are:
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Boehringer Ingelheim International GmbH. (Germany)
AstraZeneca (UK)
Johnson & Johnson Private Limited (US)
Bayer AG (Germany)
Merck & Co., Inc. (US)
Global Autoimmune Hepatitis Market Scope
The autoimmune hepatitis market is segmented on the basis of type, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Type 1
Type 2
Treatment
Medications
Corticosteroids
Immune system suppressors
Liver Transplant
Others
Diagnosis
Liver Biopsy
Blood Tests
Imaging Tests
Ultrasound
MRI
CT scan
Others
Explore More Reports:
https://dbmrresearchreports.blogspot.com/2024/04/cbctcone-beam-imaging-market-to-undergo.html
https://dbmrresearchreports.blogspot.com/2024/04/inorganic-scintillators-market-would.html
https://dbmrresearchreports.blogspot.com/2024/04/telecom-power-system-market-to-undergo_21.html
https://dbmrresearchreports.blogspot.com/2024/04/internet-of-things-iot-in-manufacturing.html
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact Us:
Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoimmune Hepatitis Market, By Type (Type 1, Type 2), Treatment (Medications, Liver Transplant, Others) here
News-ID: 3473342 • Views: …
More Releases from Data Bridge Market Research
Lecithin and Phospholipids Market to Exhibit a Remarkable CAGR of 6.72% by 2030, …
Data Bridge Market Research analyses that the lecithin and phospholipids market is expected to reach USD 2.22 billion by 2030, which is USD 1.32 billion in 2022, registering a CAGR of 6.72% during the forecast period of 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research…
Instrument Cluster Market to Exhibit a Remarkable CAGR of 5.2% by 2030, Size, Sh …
Data Bridge Market Research analyses that the global instrument cluster market which was USD 2.76 billion in 2022, is expected to reach USD 4.62 billion by 2030, and is expected to undergo a CAGR of 5.2% during the forecast period of 2023 to 2030. Vehicle type segment is dominated because the use of clutch largely depend on the vehicle type it is to be installed. In addition to the insights…
Cold Chain Market to Exhibit a Remarkable CAGR of 9.30% by 2029, Size, Share, Tr …
Data Bridge Market Research analyses that the global cold chain market growing at a CAGR of 9.30% in the forecast period of 2022-2029. The increase in the number of formal retail outlets in emerging economies leads to an increase in the need for cold storage solutions in the forecast period of 2022- 2029.
Market Definition:
The term "cold chain" refers to the combination of temperature-controlled surface transport and supply chain. It…
Analyzing Growth Trajectory and Market Dynamics of Malt Extracts: Insights into …
Latest "Malt Extracts Market" Size, Share & Trends Analysis Research Report 2024 - By Applications (Auto Sales, Employment Opportunities, Rental Properties, Pets, Other), By Types (Featured ads, Normal ad), By Segmentation analysis, Regions and Forecast to 2031. The Global Malt Extracts market Report provides In-depth analysis on the market status of the Malt Extracts Top manufacturers with best facts and figures, meaning, Definition, SWOT analysis, PESTAL analysis, expert opinions and…
More Releases for Autoimmune
Autoimmune Disease Diagnostics Market - Forecast to 2026
The findings reviewed by GME stated that the Global Autoimmune Disease Diagnostics Market would grow at a CAGR value of 8.9 percent from 2021 to 2026. Today, the advancing technology & automation, increasing awareness about risks and implications of autoimmune disease if left undiagnosed & untreated, and the awareness about the benefits of various diagnostics available are accelerating growth in the market. Also, there has been an exponential increase…
The Autoimmune Registry releases first complete list of autoimmune diseases with …
The Autoimmune Registry Inc (ARI) has published its first comprehensive List of Autoimmune Diseases: https://www.autoimmuneregistry.org/autoimmune-diseases. It includes over 150 diseases, 40 subtypes, and 60 synonyms. ARI created the list to provide patients and researchers easy access to the latest literature and information about autoimmune disease. ARI’s list is searchable and filterable, with links to peer-reviewed research, patient groups, and other resources.
Between 15 and 30 million people in…
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market.
Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html
To reduce effects of such hindrances, the new entrants are…
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan
Autoimmune disease therapeutics include…
Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment …
The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent treatment. This creates ample growth opportunity for the autoimmune treatment market, to grow at a considerable rate in the coming years. The advanced research and development facilities, and…
Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Gr …
Global Autoimmune Disease Diagnostics Market: Snapshot
The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in…
